Trials / Terminated
TerminatedNCT01812174
On-X Heart Valve - 17mm Aortic and 23mm Mitral
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- On-X Life Technologies, Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study examines the hemodynamic and hemolytic properties of two additional smaller size valves to the On-X line of valves already approved by FDA.
Detailed description
The purpose of the study is to assess the safety and efficacy of the 17mm On-X Aortic Prosthetic Heart Valve and the 23mm On-X Mitral Prosthetic Heart Valve when used to replace diseased aortic or mitral valves in human subjects. The On-X 17mm aortic valve will be implanted in approximately 20 and at least 15 patients who will be followed for at least 1 year. Patients will be any age and will require this size valve as determined in surgery but will be recruited prior to surgery based on results of preoperative screening tests. Enrollment into the 23mm mitral arm of the study has been terminated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 17mm aortic valve (On-X ) | Heart aortic valve replacement surgery: 17mm Aortic |
| DEVICE | 23mm mitral valve (On-X) | Heart mitral valve replacement surgery: 23mm Mitral |
Timeline
- Start date
- 2011-11-18
- Primary completion
- 2018-12-07
- Completion
- 2018-12-07
- First posted
- 2013-03-18
- Last updated
- 2024-03-06
- Results posted
- 2024-03-06
Locations
10 sites across 3 countries: United States, Puerto Rico, Spain
Source: ClinicalTrials.gov record NCT01812174. Inclusion in this directory is not an endorsement.